Cytochrome P450 1A1, 2E1 and GSTM1 gene polymorphisms and susceptibility to colorectal cancer in the saudi population

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 6, 2013, Pages 3761-3768

  Saeed, Hesham Mahmoud ^a,b   Alanazi, Mohammad Saud ^a   Nounou, Howaida Attia ^c   Shalaby, Manal Ali ^d   Semlali, Abdelhabib ^a   Azzam, Nahla ^e   Aljebreen, Abdeulrahan ^e   Alharby, Othman ^e   Parine, Narasimha Reddy ^e   Shaik, Jilani ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c ALEXANDRIA UNIVERSITY   (Egypt)

^d Universities and Research Institutes District   (Egypt)

^e KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Colorectal cancer; Cytochrome P450; Single nucleotide polymorphism; Xenobiotic

Indexed keywords

EID: 84882575078     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.6.3761     Document Type: Article

References (53)

1. Ates NA, Tamer L, Ates C, et al (2005). Glutathione S-transferase M1, T1, P1 genotypes and risk for development of colorectal cancer. Biochem Genet, 43, 149-63.
2. Bell DA, Taylor JA, Paulson DF, et al (1993). Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen metabolism gene glutathione S-transferase M1(GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst, 85, 1159-64.
3. Boccia S, Sayed-Tabatabaei FA, Persiani R, et al (2007). Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population. BMC Cancer, 7, 206.
4. Boyle P, Ferlay J (2005). Cancer incidence and mortality in Europe. Ann Oncol, 16, 481-8.
5. Bozina N, Bradamanye V, Loveric M (2009). Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity and cancer risk. Arch Hig Rada Toksikol, 60, 217-42.
6. Brookes AJ (1999). The essence of SNPs. Gene, 234, 177-86.
7. Carlson CS, Newman TL, Nickerson DA (2001). SNPing in the human genome. Curr Opin Chem Biol, 5, 78-85.
8. Chang BL, Zheng SL, Isaacs SD, et al (2003). Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk. Int J Cancer, 106, 375-8.
9. Chang HY, Yang X (2000). Proteases for cell suicide: functions and regulation of caspases. Microbiol Mol Biol Rev, 64, 821-46.
10. Corchero J, Primprale S, Kimura S, et al (2001) Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation. Pharmacogenetics, 11, 1-6.
11. Darazy M, Balbaa M, Mugharbil A, et al (2011). CYP1A1, CYP2E1, and GSTM1 Gene Polymorphisms and Susceptibility to Colorectal and Gastric Cancer Among Lebanese. Genet Test Mol Biomarkers, 15, 423-9.
12. Dil Llio C, Del Boccio G, Casaccia R, et al (1987). Selenium level and glutathione dependent enzyme activities in normal and neoplastic human lung tissues. Carcinogenesis, 8, 281-4.
13. Gao Y, Cao Y, Tan A, et al (2010). Glutathione S-transferase M1 polymorphisms and sporadic colorectal cancer risk: an updating meta analysis and HuGE review of 36 case-control studies. Ann Epidemiol, 20, 108-21.
14. Garte S, Gaspari L, Alexandrie AK, et al (2001). Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev, 10, 1239-48.
15. Gelboin H (1980). Benzo[a]pyrene metabolism, activation and carcinogenesis: role of regulation of mixed-function oxidases and related enzymes. Physio Rev, 60, 1107-66.
16. Guengerich FP, Shimada T (1998). Activation of procarcinogens by human cytochrome P450 enzymes. Mutat Res, 400, 201-13.
17. Haufroid V, Buchet JP, Gardinal S, et al (2002). Cytochrome P450 2E1 phenotyping by the measurement of the chloroxazone metabolic ratio: assessment of its usefulness in workers exposed to styrene. Int Arch Occup Environ Health, 75, 453-8.
18. Hayashi S, Watanabe J, Nakachi K, et al (1991). Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450 1A1 gene. J Biochem (Tokyo), 110, 407-11.
19. Hayashi S, Watanabe J, Kawajiri K (1991). Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem, 110, 559-65.
20. Heavey PM, McKenna D, Rowland IR (2004). Colorectal cancer and relationship between genes and the environment. Nutr Cancer, 48, 124-41.
21. Hemminki K, Czene K (2002). Attributable risks of familial cancer from the family-cancer database. Cancer Epidemiol Biomarkers Prev, 12, 1638-44.
22. Induski JA, Lutz W (2000). Metabolic genotype in relation to individual susceptibility to environmental carcinogens. Int Arch Occup Environ Health, 73, 71-85.
23. Katoh T, Nagata N, Kuroda Y, et al (1996). Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis, 17, 1855-9.
24. Kellerman G, Shaw CR, Luyten-Kellerman M (1973). Arylhydrocarbon hydroxylase and bronchogenic carcinoma. N Engl J Med, 289, 934-7.
25. Ketterer B, Harris JM, Talaska G, et al (1992). The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ Health Perspect, 98, 87-94.
26. Kiss I, Ne'meth A, Bogner B, et al (2004) Polymorphisms of glutathione-S-transferase and arylamine N- acetyltransferase enzymes and susceptibility to colorectal cancer. Anticancer Res, 24, 3965-70.
27. Landi MT, Bertazzi PA, Shields PG, et al (1994). Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics, 4, 242-6.
28. Lionel L, Abdelhabib S, Marc B, et al (2010). Crosstalk between T cells and bronchial fibroblasts obtained from asthmatic subjects involves CD40L/a5'1 interaction. Mol Immunol, 47, 2112-8.
29. Liu Y, Meng XW, Zhou LY, et al (2009). Genetic polymorphism and mRNA levels of cytochrome P450IIE1 and glutathione S-transferase P1 in patients with alcoholic liver disease in different nationalities. Hepatobiliary Pancreat Dis Int, 8, 162-7.
30. Lucas D, Menez C, Girre C, et al (1995). Cytochrome P450 2E1 genotype and chlorzoxazone metabolism in healthy and alcoholic Caucasian subjects. Pharmacogenetics, 5, 298-304.
31. Martinez C, Martin F, Fernandez JM, et al (2006). Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics, 7, 711-8.
32. Nisa H, Kono S, Yin G, et al (2010). Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka colorectal cancer study. BMC Cancer, 10, 274.
33. Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics 2002. CA Cancer J Clin, 55, 74-108.
34. Piao JM, Shin MH, Kweon SS, et al (2009). Glutathione- Stransferase (GSTM1, GSTT1) and the risk of gastrointestinal cancer in a Korean population. World J Gastroenterol, 15, 5716-21.
35. Potter JD (1999). Colorectal cancer: molecules and populations. J Natl Cancer Inst, 91, 916-32.
36. Rawal RM, Patel DD, Patel BP, et al (1999). Assessment of glutathione S-transferase and glutathione reductase in patients with squamous cell carcinoma of buccal musosa. Int J Cancer, 83, 727-31.
37. Raunio H, Husgafvel-Pursiainen K, Anttila S, et al (1995). Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility. Gene, 159, 113-21.
38. Roses AD (2000). Pharmacogenetics and the practice of medicine. Nature, 405, 857-65.
39. Sachidanandam R, Weissman D, Schmidt SC, et al (2001). A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature, 409, 928-33.
40. Saadat I, Saadat M (2001). Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers. Cancer Lett, 169, 21-6.
41. Sanger F, Nicklen S, Coulson A (1977). DNA sequencing with chain terminating inhibitor. Proc Natl Acad Sci (USA), 74, 5463-7.
42. Sgambato A, Campisi B, Zupa A, et al (2002). Glutathione S-transferase (GST) polymorphisms as risk factors for cancer in a highly homogeneous population from southern Italy. Anticancer Res, 22, 3647-52.
43. Slattery ML, Samowtiz W, Ma K, et al (2004). CYP1A1, cigarette smoking, and colon and rectal cancer. Am J Epidemiol, 160, 842-52.
44. Sivarman L, Leatham MP, Yee J (1994). CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res, 54, 3692-5.
45. Tamer L, Ates NA, Ates C, et al (2005). Glutathione S-transferase M1, T1 and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk. Cell Biochem Funct, 23, 267-72.
46. Taspinar M, Ayodos SE, Comez O, et al (2008). CYP1A1, GST gene polymorphisms and risk of chronic myeloid leukaemia. Swiss Med Wkly, 138, 12-7.
47. Terry KL, Garner EO, Vitonis AF, et al (2003). Interaction between CYP1A1 polymorphic variants and dietary exposures influencing ovarian cancer risk. Cancer Epidemiol Biomarkers Prev, 12, 187-90.
48. Wang H, Zhou Y, Zhuang W, et al (2010). Glutathione Stransferase M1 null genotype associatedwith gastric cancer among Asians. Dig Dis Sci, 55, 1824-30.
49. Welfare M, Monesola Adeokun A, Bassendine MF, et al (1999). Polymorphism in GSTP1, GSTM1, and susceptibility to colorectal cancer. Cancer Epidemiol Biomarkers Prev, 8, 289-92.
50. Wenlei Z, Liang Z, Zhinqun Q, et al (2012). Does cytochrome P450 1A1 MspI polymorphism increase acute lymphoblastic leukemia risk? Evidence from 2013 cases and 2903 controls. Gene, 510, 14-21.
51. Wu MS, Chen CJ, Lin MT, et al (2002). Genetic polymorphisms of cytochrome P450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan. Int J Colorectal Dis, 17, 338-43.
52. Ye Z, Parry JM (2002). Genetic polymorphisms in the cytochrome P450 1A1, glutathione S- transferase M1 and T1, and susceptibility to colon cancer. Teratog Carcinog Mutagen, 22, 385-92.
53. Zhou SF, Liu JP, Chowbay B (2009) Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev, 41, 89-295.